Ovarian cancer stem cells: What progress have we made?

Area of Science:

• Gynecologic Oncology
• Cancer Stem Cell Biology
• Translational Cancer Research

Background:

• Ovarian cancer (OvCa) remains a leading cause of cancer death due to diagnostic challenges, chemo-resistance, and tumor heterogeneity.
• Cancer stem cells (CSCs) are implicated in OvCa recurrence and resistance to therapy due to their self-renewal and adaptability.
• The plasticity of CSCs and their signaling pathways present a significant hurdle for effective targeted therapies.

Purpose of the Study:

• To review the current understanding of ovarian CSC markers and their associated signaling pathways.
• To elucidate the role of CSCs in driving therapeutic resistance and disease recurrence in ovarian cancer.
• To highlight ongoing clinical trials targeting the CSC population in OvCa.

Main Methods:

• Literature review of current research on ovarian CSCs.
• Analysis of CSC characteristics, including self-renewal, differentiation, and plasticity.
• Examination of signaling pathways exploited by CSCs for survival and proliferation.
• Overview of clinical trial strategies aimed at targeting CSCs in ovarian cancer.

Main Results:

• Ovarian CSCs possess unique markers and exhibit remarkable adaptability to therapeutic and microenvironmental pressures.
• CSCs contribute significantly to chemotherapy resistance and tumor recurrence in ovarian cancer.
• Targeting CSC-specific pathways holds potential for improving treatment efficacy and patient outcomes.

Conclusions:

• Understanding ovarian CSC biology is crucial for developing novel therapeutic strategies.
• Targeting CSCs may overcome resistance mechanisms and prevent recurrence in ovarian cancer.
• Further research and clinical trials are needed to validate CSC-targeted therapies for improved patient survival.